ClinConnect ClinConnect Logo
Search / Trial NCT00477776

Maxolon to Improve Breastmilk Supply in Diabetic Women: a Randomised Controlled Trial

Launched by NATIONAL UNIVERSITY HOSPITAL, SINGAPORE · May 23, 2007

Trial Information

Current as of August 20, 2025

Completed

Keywords

Beginning Of Breastfeeding

ClinConnect Summary

The study aims to determine the breastfeeding initiation and duration rate of a cohort of pregnant women with gestational diabetes(diet-controlled) and insulin dependent and pre-existing diabetes, assess the impact of a post natally administered galactogogue, metoclopramide on the milk volume production and timing of lactogenesis II in diabetic women on diet control and insulin and determine the prolactin response to lactation among diabetic women on diet control and insulin.

Gender

FEMALE

Eligibility criteria

  • Inclusion Criteria:
  • All pregnant women with pregestational or gestational diabetes under diet or insulin control
  • Exclusion Criteria:
  • Patient who have epilepsy or on anti-seizure medications,
  • Patients who have a history of significant depression or are on antidepressant drugs
  • Patients who have pheochromocytoma or uncontrolled hypertension
  • Patients who have intestinal bleeding or obstruction
  • Patient with known allergy or prior reaction to metoclopramide
  • Patient with HIV infection
  • Current pregnancy complicated by fetal congenital anomalies and multiple fetuses

About National University Hospital, Singapore

National University Hospital (NUH) in Singapore is a leading academic medical institution dedicated to advancing healthcare through innovative research and clinical excellence. As a prominent sponsor of clinical trials, NUH emphasizes a multidisciplinary approach, integrating cutting-edge medical research with high-quality patient care. The hospital collaborates with various stakeholders, including academic institutions and industry partners, to explore new therapies and improve treatment outcomes across a wide range of medical disciplines. Committed to ethical standards and patient safety, NUH plays a pivotal role in shaping the future of medicine in Singapore and beyond.

Locations

Singapore, , Singapore

Patients applied

0 patients applied

Trial Officials

Chong Y S, MBBS,MRACOG

Principal Investigator

National University Hospital and National University of Singapore

Citra Mattar, MBBS

Principal Investigator

National University Hospital, Singapore

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported

Similar Trials